Background: Patients with diabetes who are hospitalized with COVID-19 have been found to have increased lengths of stay and greater intensive care unit utilization compared to those without diabetes. Diabetic ketoacidosis (DKA) is an acute diabetes emergency that accounts for a high number of hospitalizations, hospital readmissions, and healthcare utilization. Our study aims to evaluate […]

Case Presentation: A 46-year-old male with Type 2 DM presented with 2 weeks of malaise, 3 days of cough, dyspnea, and fatigue. His wife noted his breath smelt different over the last 2 weeks. He had a thyroidectomy for multinodular goiter 2 weeks prior and started a ketogenic, intermittent fasting diet after. Medications include empagliflozin […]

Background: Diabetic Ketoacidosis (DK)A at our center has historically been managed in the intensive care unit (ICU) utilizing low-dose insulin infusion. According to the American Diabetes Association (ADA) and a 2016 Cochrane review, cases of mild to moderate DKA can be safely managed on general medical floors utilizing subcutaneous short-acting insulin. Prior studies have demonstrated […]

Case Presentation: A 55-year-old man with a history of homelessness, poorly controlled type 2 diabetes treated with insulin and complicated by recurrent diabetic ketoacidosis (DKA), peripheral vascular disease and neuropathy with foot ulcers, severe autonomic neuropathy with postural hypotension and recurrent syncope treated chronically with midodrine and fludrocortisone, and chronic heart failure with mid-range ejection […]

Case Presentation: TS is a 58 year-old male with a past medical history of prediabetes, pulmonary embolism, and stage II colon cancer treated via hemicolectomy in 2016 who presented to the hospital with dyspnea and altered mental status. On exam, he was febrile to 38.6 degrees Celsius. His abdomen was distended and diffusely tender to […]

Case Presentation: A 60 year old female with small cell cancer, type 2 diabetes on an insulin pump and empagliflozin, and recently diagnosed pulmonary embolus (PE) on apixaban presents to the hospital with intractable nausea with vomiting and symptomatic tachycardia. This patient presented 1 month prior with dyspnea and tachycardia and was found to have […]